MAOA and hepatocellular carcinoma: Noteworthy, a recent study evaluating the effects of antidepressants in HCC cells described that the administration of moclobemide, the reversible MAO-A inhibitor, did not decrease HCC cell viability [142], supporting previous reports of a low MAO-A expression in this type of cancer tissue.